Search research articles
Contact Us
Filters
Showing results (41-50 of 79) with videos related to
Page
of 8
Sort By:
International Journal of Cancer
|
July 26, 2021
Camrelizumab plus oxaliplatin-based chemotherapy as first-line therapy for advanced biliary tract cancer: A multicenter, phase 2 trial
Xinni Chen, Shukui Qin, Shanzhi Gu, et al.
American Journal of Translational Research
|
November 10, 2017
Image-guided dendritic cell-based vaccine immunotherapy in murine carcinoma models
Bin Wang, Chong Sun, Sijia Wang, et al.
International Journal of Biological Sciences
|
January 3, 2024
VEGFA/NRP-1/GAPVD1 axis promotes progression and cancer stemness of triple-negative breast cancer by enhancing tumor cell-macrophage crosstalk
Lu Wang, Lifen Zhang, Lin Zhao, et al.
Chinese Medical Journal
|
June 9, 2026
Anti-PD-1 monoclonal antibody suppresses hepatitis B virus in patients with hepatocellular carcinoma
Chuanhua Zhao, Yanqiao Zhang, Gang Wang, et al.
Cancer Science
|
March 26, 2018
Ribosome display and selection of single-chain variable fragments effectively inhibit growth and progression of microspheres in vitro and in vivo
Shangke Huang, Lu Feng, Gaili An, et al.
BMC Cancer
|
May 6, 2025
FLT3LG modulates the infiltration of immune cells and enhances the efficacy of anti-PD-1 therapy in lung adenocarcinoma
Fengyu Zhao, Han Bai, Yiwei Liu, et al.
Liver Cancer
|
August 20, 2021
Atezolizumab plus Bevacizumab versus Sorafenib in the Chinese Subpopulation with Unresectable Hepatocellular Carcinoma: Phase 3 Randomized, Open-Label IMbrave150 Study
Shukui Qin, Zhenggang Ren, Yin-Hsun Feng, et al.
NPJ Precision Oncology
|
September 12, 2024
First-in-human study of DP303c, a HER2-targeted antibody-drug conjugate in patients with HER2 positive solid tumors
Jian Zhang, Yiqun Du, Yanchun Meng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 24, 2023
A Phase 1/2 Multicenter Randomized Trial of Local Ablation plus Toripalimab versus Toripalimab Alone for Previously Treated Unresectable Hepatocellular Carcinoma
Chunhui Zhou, Yan Li, Jiaping Li, et al.
Eclinicalmedicine
|
October 17, 2022
Ramucirumab as second-line treatment in Chinese patients with advanced hepatocellular carcinoma and elevated alpha-fetoprotein after sorafenib (REACH-2 China): A randomised, multicentre, double-blind study
Guoliang Shao, Yuxian Bai, Xianglin Yuan, et al.
Page
of 8
Search research articles
Search
Showing results (41-50 of 79) with videos related to
Sort By:
Page
of 8
International Journal of Cancer
|
July 26, 2021
Camrelizumab plus oxaliplatin-based chemotherapy as first-line therapy for advanced biliary tract cancer: A multicenter, phase 2 trial
Xinni Chen, Shukui Qin, Shanzhi Gu, et al.
American Journal of Translational Research
|
November 10, 2017
Image-guided dendritic cell-based vaccine immunotherapy in murine carcinoma models
Bin Wang, Chong Sun, Sijia Wang, et al.
International Journal of Biological Sciences
|
January 3, 2024
VEGFA/NRP-1/GAPVD1 axis promotes progression and cancer stemness of triple-negative breast cancer by enhancing tumor cell-macrophage crosstalk
Lu Wang, Lifen Zhang, Lin Zhao, et al.
Chinese Medical Journal
|
June 9, 2026
Anti-PD-1 monoclonal antibody suppresses hepatitis B virus in patients with hepatocellular carcinoma
Chuanhua Zhao, Yanqiao Zhang, Gang Wang, et al.
Cancer Science
|
March 26, 2018
Ribosome display and selection of single-chain variable fragments effectively inhibit growth and progression of microspheres in vitro and in vivo
Shangke Huang, Lu Feng, Gaili An, et al.
BMC Cancer
|
May 6, 2025
FLT3LG modulates the infiltration of immune cells and enhances the efficacy of anti-PD-1 therapy in lung adenocarcinoma
Fengyu Zhao, Han Bai, Yiwei Liu, et al.
Liver Cancer
|
August 20, 2021
Atezolizumab plus Bevacizumab versus Sorafenib in the Chinese Subpopulation with Unresectable Hepatocellular Carcinoma: Phase 3 Randomized, Open-Label IMbrave150 Study
Shukui Qin, Zhenggang Ren, Yin-Hsun Feng, et al.
NPJ Precision Oncology
|
September 12, 2024
First-in-human study of DP303c, a HER2-targeted antibody-drug conjugate in patients with HER2 positive solid tumors
Jian Zhang, Yiqun Du, Yanchun Meng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 24, 2023
A Phase 1/2 Multicenter Randomized Trial of Local Ablation plus Toripalimab versus Toripalimab Alone for Previously Treated Unresectable Hepatocellular Carcinoma
Chunhui Zhou, Yan Li, Jiaping Li, et al.
Eclinicalmedicine
|
October 17, 2022
Ramucirumab as second-line treatment in Chinese patients with advanced hepatocellular carcinoma and elevated alpha-fetoprotein after sorafenib (REACH-2 China): A randomised, multicentre, double-blind study
Guoliang Shao, Yuxian Bai, Xianglin Yuan, et al.
Page
of 8